|
(2S,4S,5R,6R)- 5- Acetamido- 2- [(2R,3R,4S,5S,6R)- 2- [(2S,3R,4R,5S,6R)- 3- acetamido- 2- [(2R,3S,4S,5R,6S)- 2- [[(2R,3R,4R,5S,6R)- 3- acetamido- 4- hydroxy- 6- (hydroxymethyl)- 5- [(2S,3R,4S,5R,6R)- 3,4,5- trihydroxy- 6- (hydroxymethyl)oxan- 2- yl]oxyoxan- 2- yl]oxymethyl]- 3,5- dihydroxy- 6- [(2R,3S,4R,5R)- 4,5,6- trihydroxy- 2- (hydroxymethyl)oxan- 3- yl]oxyoxan- 4- yl]oxy- 6- (hydroxymethyl)- 5- [(2S,3S,4R,5S,6S)- 3,4,5- trihydroxy- 6- methyloxan- 2- yl]oxyoxan- 4- yl]oxy- 3,5- dihydroxy- 6- (hydroxymethyl)oxan- 4- yl]oxy- 4- hydroxy- 6- [(1R,2R)- 1,2,3- trihydroxypropyl]oxane- 2- carboxylic acid |
|
CHEBI:148614 |
|
 
This entity has been manually annotated by a third party.
|
|
Gareth Owen
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C57H95N3O43/c1- 13- 28(72) 34(78) 38(82) 52(90- 13) 99- 44- 23(11- 66) 95- 51(27(60- 16(4) 69) 46(44) 100- 55- 41(85) 48(31(75) 20(8- 63) 93- 55) 103- 57(56(87) 88) 5- 17(70) 25(58- 14(2) 67) 45(102- 57) 29(73) 18(71) 6- 61) 101- 47- 32(76) 24(96- 54(40(47) 84) 98- 43- 21(9- 64) 91- 49(86) 37(81) 36(43) 80) 12- 89- 50- 26(59- 15(3) 68) 33(77) 42(22(10- 65) 94- 50) 97- 53- 39(83) 35(79) 30(74) 19(7- 62) 92- 53/h13,17- 55,61- 66,70- 86H,5- 12H2,1- 4H3,(H,58,67) (H,59,68) (H,60,69) (H,87,88) /t13- ,17- ,18+,19+,20+,21+,22+,23+,24+,25+,26+,27+,28+,29+,30- ,31- ,32- ,33+,34+,35- ,36+,37+,38- ,39+,40+,41+,42+,43+,44+,45+,46+,47- ,48- ,49?,50+,51- ,52- ,53- ,54- ,55- ,57- /m0/s1 |
BIWJJPKGZNADNL-HAFFYROHSA-N |
O([C@@H] 1[C@@H] (NC(=O) C) [C@@H] (O[C@@H] ([C@H] 1O[C@@H] 2O[C@H] ([C@@H] (O) [C@@H] (O) [C@@H] 2O) C) CO) O[C@H] 3[C@@H] (O) [C@H] (O[C@@H] (O[C@H] 4[C@H] (O) [C@@H] (O) C(O[C@@H] 4CO) O) [C@@H] 3O) CO[C@@H] 5O[C@@H] ([C@@H] (O[C@@H] 6O[C@@H] ([C@H] (O) [C@H] (O) [C@H] 6O) CO) [C@H] (O) [C@H] 5NC(=O) C) CO) [C@@H] 7O[C@@H] ([C@H] (O) [C@H] (O[C@] 8(O[C@H] ([C@H] (NC(=O) C) [C@@H] (O) C8) [C@H] (O) [C@H] (O) CO) C(O) =O) [C@H] 7O) CO |
|
Outgoing
|
(2S,4S,5R,6R)- 5- Acetamido- 2- [(2R,3R,4S,5S,6R)- 2- [(2S,3R,4R,5S,6R)- 3- acetamido- 2- [(2R,3S,4S,5R,6S)- 2- [[(2R,3R,4R,5S,6R)- 3- acetamido- 4- hydroxy- 6- (hydroxymethyl)- 5- [(2S,3R,4S,5R,6R)- 3,4,5- trihydroxy- 6- (hydroxymethyl)oxan- 2- yl]oxyoxan- 2- yl]oxymethyl]- 3,5- dihydroxy- 6- [(2R,3S,4R,5R)- 4,5,6- trihydroxy- 2- (hydroxymethyl)oxan- 3- yl]oxyoxan- 4- yl]oxy- 6- (hydroxymethyl)- 5- [(2S,3S,4R,5S,6S)- 3,4,5- trihydroxy- 6- methyloxan- 2- yl]oxyoxan- 4- yl]oxy- 3,5- dihydroxy- 6- (hydroxymethyl)oxan- 4- yl]oxy- 4- hydroxy- 6- [(1R,2R)- 1,2,3- trihydroxypropyl]oxane- 2- carboxylic acid
(CHEBI:148614)
is a
neuraminic acids
(CHEBI:25508)
|
|
5- acetamido- 3,5- dideoxy- D- glycero- alpha- D- galacto- non- 2- ulopyranosylonic acid- (2- >3)- beta- D- galacto- hexopyranosyl- (1- >3)- [6- deoxy- alpha- L- galacto- hexopyranosyl- (1- >4)]- 2- acetamido- 2- deoxy- beta- D- gluco- hexopyranosyl- (1- >3)- [beta- D- galacto- hexopyranosyl- (1- >4)- 2- acetamido- 2- deoxy- beta- D- gluco- hexopyranosyl- (1- >6)]- beta- D- galacto- hexopyranosyl- (1- >4)- D- gluco- hexopyranose
|
SUBMITTER
|
NeuAc(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)[Gal(b1-4)GlcNAc(b1-6)]Gal(b1-4)Glc
|
SUBMITTER
|
WURCS=2.0/5,8,7/[a2122h- 1x_1- 5][a2112h- 1b_1- 5][a2122h- 1b_1- 5_2*NCC/3=O][Aad21122h- 2a_2- 6_5*NCC/3=O][a1221m- 1a_1- 5]/1- 2- 3- 2- 4- 5- 3- 2/a4- b1_b3- c1_b6- g1_c3- d1_c4- f1_d3- e2_g4- h1
|
SUBMITTER
|
|